GLP-1 medications are everywhere right now. Friends are talking about them. Social media is celebrating them. Primary care offices are prescribing them at record rates. And yes, some women are losing a significant amount of weight.
But here’s what I’m also seeing.
Women over 40 who are losing less than expected. Women who drop weight quickly and then plateau.
Women who feel weaker instead of stronger. Women watching the scale fall while their energy falls with it.
And they’re confused — because this was supposed to be the solution.
If only.
It’s true that medications like semaglutide and tirzepatide are powerful appetite-regulating tools. They improve insulin signaling. They reduce hunger cues. They help stabilize blood sugar.
But they are not — and were never designed to be — magic bullets.
So let’s break down the disconnect.
What GLP-1 Medications Do
GLP-1 medications mimic a hormone your body naturally releases after you eat. That hormone signals fullness to the brain and helps regulate glucose levels. When that fullness signal is strengthened with medication, appetite drops and blood sugar becomes more stable.
For women with significant insulin resistance or type 2 diabetes, this can be transformative. Many women lose 15–25% of their body weight. Reduced caloric intake combined with improved insulin dynamics often leads to meaningful fat loss and lower cardiometabolic risk.
In that context, these medications make sense. They are doing exactly what they were designed to do.
But the key word here is context.
They were never meant to be a weight-loss free-for-all for every woman, regardless of her underlying physiology.
Why GLP-1 Meds Fall Short
Weight gain after 40 is rarely driven by hunger alone. It’s driven by shifting hormones, declining muscle mass, stress physiology, disrupted sleep, and subtle changes in thyroid dynamics that accumulate over time.Curbing appetite lowers intake. It does not automatically repair those deeper metabolic shifts.
These medications do not restore declining estrogen. They do not replace lost progesterone. They do not optimize thyroid conversion. They do not rebuild muscle. They do not repair fragmented sleep. They do not calm chronically elevated cortisol. They do not address gut dysfunction, intestinal infections, or food sensitivities.
And trust me — from one over-40 woman to another — those variables often matter just as much as appetite. Sometimes more.
What Happens When GLP-1 Meds Are Stopped
GLP-1 medications suppress appetite while you’re taking them. But once they’re discontinued, hunger signals rejoin the party, making it harder to “just say no” to just one more cookie.
There’s another issue that rarely gets discussed clearly. In clinical trials, roughly one-quarter to nearly 40% of total weight lost on these medications comes from lean mass—not just fat. Lean mass includes muscle, and muscle is metabolically active tissue.
Less muscle means fewer calories burned at rest. So when appetite returns and eating normalizes, your metabolic engine may be running at a lower idle than before.
Add in unaddressed hormone shifts, thyroid sluggishness, poor sleep, or chronic stress — and the rebound risk climbs even higher.
Here’s the truth: Long-term outcomes depend heavily on what was built underneath the medication: muscle, metabolic flexibility, hormonal balance, sleep quality, and stress resilience. Without those foundations, the body tends to drift back toward its previous set point.
Potential Side Effects
Like all medications, GLP-1s come with trade-offs. Nausea, constipation, slowed gastric emptying, fatigue, and under-fueling are common. Gallbladder issues can develop. Lean mass can decline. And the boxed warning about thyroid C-cell tumors — drawn from rodent studies — is part of the fine print.
Most of these risks can be managed when someone is paying attention. But let’s call this what it is: this is a pharmaceutical lever. It’s not a lifelong substitute for sleep, muscle, hormones, and metabolic repair.
A More Realistic Approach to Permanent Weight Loss
GLP-1 medications can be useful tools in the right clinical setting. They can help interrupt severe insulin resistance and reduce cardiometabolic risk. For some women, they provide needed momentum to get the ball finally rolling in the right direction.
But for most women over 40, sustainable fat loss almost always requires more than appetite suppression.
It requires preserving — and ideally building — muscle, optimizing thyroid function, addressing hormone deficiencies where appropriate, protecting sleep, and calming chronic stress physiology. In other words, it requires rebuilding metabolism, not just cutting back calories going in.
GLP-1 medications may play a role in that strategy. They just aren’t the whole strategy.And if you’re feeling stuck despite doing “everything right,” it doesn’t mean you’re failing.
It means your metabolism deserves a more comprehensive plan.
You can learn more about hormones, stress, and other hidden metabolic factors that keep women over 40 stuck in my book, Weight Loss After 40 — now available on Amazon.